Regulatory Expertise

TSI stays ahead of the curve with a seasoned and accomplished team of global regulatory professionals.

We have licence approval to manufacture both lower risk (AUST L) and higher risk (AUST R) medicines.

Our vast regulatory experience comes from our direct sales locations in China, Australia, Europe, Japan, and the United States as well as from our customers located in over 34 countries.

These activities equip TSI with the necessary ‘in country’ regulatory resources, knowledge, and tools that help TSI address and resolve difficult regulatory challenges.